Your browser doesn't support javascript.
loading
Development of a Mass Spectrometry-Based Method for Quantification of Ustekinumab in Serum Specimens.
Scheffe, Nina; Schreiner, Rupert; Thomann, Anne; Findeisen, Peter.
Affiliation
  • Scheffe N; MVZ Laboratory Dr. Limbach & Colleagues, Heidelberg, Germany.
  • Schreiner R; MVZ Laboratory Dr. Limbach & Colleagues, Heidelberg, Germany.
  • Thomann A; Department of Medicine II, Medical Faculty Mannheim of the University of Heidelberg, Theodor Kutzer Ufer 1-3, 68167 Mannheim, Germany; and.
  • Findeisen P; MVZ Laboratory Dr. Limbach & Colleagues, Heidelberg, Germany.
Ther Drug Monit ; 42(4): 572-577, 2020 08.
Article in En | MEDLINE | ID: mdl-31985551
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Serum / Tandem Mass Spectrometry / Ustekinumab Type of study: Prognostic_studies Limits: Humans Language: En Journal: Ther Drug Monit Year: 2020 Type: Article Affiliation country: Germany
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Serum / Tandem Mass Spectrometry / Ustekinumab Type of study: Prognostic_studies Limits: Humans Language: En Journal: Ther Drug Monit Year: 2020 Type: Article Affiliation country: Germany